Microbiota-derived short-chain fatty acids control cGVHD development by regulating antibody production

Authors: Wolfe, Alex E; Ho, Tam; Chakka, Saranya Rani; Yeh, Albert C; Mirimo-Martinez, Mercy; Bhise, Shruti S; Hsu, Yvonne; Notestine, Alison A; Pahmeier, Felix; Jaycox, Jillian R; Wang, Huiqi; Stewart, Giulia E; Glabman, Raisa; Turan, Ali; Ghale, Romina; Peled, Jonathan U; Cao, Shijie; Hill, Geoffrey R; Ring, Aaron M; van den Brink, Marcel R M; Furlan, Scott N; Markey, Kate A

Source journal: Blood (2026-11-16)

DOI: 10.1182/blood.2026034453

Abstract

Chronic graft-versus-host disease (cGVHD) contributes substantially to morbidity and mortality in allogeneic hematopoietic stem cell transplant recipients. Microbe-derived short-chain fatty acids (SCFA) exert diverse local effects on the intestinal mucosa. We previously reported that a relative deficiency of SCFA in the circulation of transplant patients was associated with an increased incidence of cGVHD. We therefore hypothesized that circulating SCFA were unrecognized immunomodulators, generating protective effects after transplantation. We examined the role of SCFA butyrate and propionate in mouse models of cGVHD and now report that systemic administration of either butyrate or propionate mitigates cGVHD and improves survival. Exogenous SCFA treatment reduced pathogenic hyperexpanded B cells and recipient-specific IgA in the circulation, as well as decreasing the total alloantibody pool, defined using rapid extracellular antigen profiling (REAP). Our findings uncover a mechanism by which the intestinal microbiome plays a role in regulating antibody-dependent cGVHD pathogenesis and has implications for other antibody-mediated pathologies.

Read the full text

Related topics

Related open access articles

Abstract and bibliographic data from PubMed (U.S. National Library of Medicine). Copyright of the abstract belongs to the original publisher or authors.